Press release
Stem Cell Umbilical Cord Blood (UCB) Market Experience Exponential Growth in Future
Stem Cell Umbilical Cord Blood (UCB) Market
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost-effective method of treatment with fewer side effects. Global stem cell umbilical cord blood (UCB) market accounted for $6.5 billion in 2012, and is projected to reach $56.4 billion by 2020 registering a CAGR of 33.4% during the forecast period. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies. This is set to propel the growth of stem cell umbilical cord blood (UCB) market in near future. Athersys, California Stem Cell Inc., and Cytori Therapeutics Inc. are engaged in the development of novel stem cell therapies from cord blood. Ethical issues regarding cord blood sample application is creating biasness among donor, which is majorly influencing the stem cell umbilical cord blood (UCB) market.
Access Full Summary at : https://www.alliedmarketresearch.com/stem-cell-umbilical-cord-blood-ucb-market
Intense competition among stem cell umbilical cord blood (UCB) market players has been witnessed with the companies trying to create brand awareness. This is therefore, compelling the market players to formulate market based strategies. Cord blood stem cell is the only type of stem cell that is stored in controlled condition due to its lower volume higher cell count feature. Storage service segment is expected grow at 33.4% CAGR from 2013-2020 in the global stem cell umbilical cord blood (UCB) market.
Key Benefits
• This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market
• Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision
• Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report
• Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions
• SWOT analysis and strategic developments included in the report for Key players: Advanced Cell Technology, Inc. (USA), Athersys, California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast, Opexa Therapeutics Geron Corporation, Neostem Inc.
Key Market Segments:
By Storage
• Public cord blood banks
• Private cord blood banks
• Public Vs. Private UCB banks
By Technology
• Stem Cell Transplant
• Autologous transplant
• Allogenic transplant
• Transplant Medicine
• Regenerative Medicine
• Others
• Cord Blood Banking
• Blood Transfusion
• Cell Based Genetics
By Geography
• UCB market in North America
• UCB market in Europe
• UCB market in Asia-pacific
• UCB market in ROW
Get Sample PDF Brochure at : https://www.alliedmarketresearch.com/request-sample/114
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stem Cell Umbilical Cord Blood (UCB) Market Experience Exponential Growth in Future here
News-ID: 1163306 • Views: …
More Releases from Allied Market Research
Renal Denervation Market to Exceed USD $4.5 Billion by 2030 | Allied Market Rese …
Renal denervation is a medical procedure that uses radiofrequency ablation or other methods to disrupt the activity of nerves that surround the kidneys. These nerves are part of the sympathetic nervous system, which controls various bodily functions, including blood pressure regulation. During renal denervation, upper chamber and lower chamber of the heart beat irregularly, chaotically, and out of sync, which can cause shortness of breath, chest pain, weakness, lightheadedness, or…
The Booming Surgical Equipment Market Is Projected to Reach $59 Billion by 2032
Allied Market Research recently said the surgical equipment industry has been growing steadily in recent years, driven by advances in technology, increasing demand for minimally invasive surgeries, and rising healthcare expenditures. The global surgical equipment market size was valued at $35.6 billion in 2022, and is projected to reach $59 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. Surgical equipment refers to the various tools,…
ALS Treatment Market to Reach US$ 1.04 Billion by 2032, Growing at 4.6% CAGR
The global amyotrophic lateral sclerosis (ALS) treatment market is entering a critical phase of growth as unmet therapeutic needs and research momentum converge. Current figures indicate a market value of US$ 662.3 million in 2022, with a projected increase to US$ 1,038.94 million by 2032, which equates to a CAGR of 4.6% from 2023 to 2032. ALS is a severe neurodegenerative disease affecting nerve cells in the brain and spinal…
Aircraft Engine Forging Market to Garner $5 Billion, Globally, By 2032 At 6.9% C …
Aircraft engine forging industry size was valued at $2.6 billion in 2022, and is estimated to garner $5 billion by 2032, growing at a CAGR of 6.9% from 2023 to 2032.
The demand for lightweight materials, such as titanium, aluminum, and advanced alloys, aimed at improving fuel efficiency and overall performance of aircraft engines. Moreover, there is surge in air travel demand that led airlines to expand their fleets, necessitating the…
More Releases for UCB
Fibromyalgia Market: Expanding Revenue Landscape to 2034 - DelveInsight | UCB Ph …
The Key Fibromyalgia Companies in the market include - Tonix Pharmaceutical, UCB Biopharma SRL, GlaxoSmithKline, UCB Pharma, Pierre Fabre Medicament, UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, AstraZeneca, RiboCor, Inc., Bial - Portela C S.A, and others.
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States,…
Epilepsy Market Expected to Gain Momentum Through 2034, According to DelveInsigh …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Epilepsy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveI …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Fibromyalgia Market to Exhibit Rapid Growth Rate During the Forecast Period (202 …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Forecast
https://www.delveinsight.com/sample-request/fibromyalgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Fibromyalgia…
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing…
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports…
